March 2, 2017
by Business Wire
Neocis Inc. today announced that the company has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market Yomi®, a robotic guidance system for dental implant procedures. Yomi is a computerized navigational system intended to provide assistance in both the planning (pre-operative) and the surgical (intra-operative) phases of dental implantation surgery. The system provides software to preoperatively plan dental implantation procedures and provides navigational guidance of the surgical instruments.
Dental implant surgery is the standard of care for replacing missing teeth. Nearly 4 million implants are placed annually in the United States by 15,000 dental specialists and nearly 150,000 general practice dentists. More than 15 million implants are placed annually worldwide. The surgical robotics market is growing significantly across several medical markets and is estimated to reach $20 billion by 2021. Yomi is the only surgical robotic system focused on the dental industry.
To view the full story, please click here.
Read our most recent Oral Health issue on implantology – click here for more.
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.